1. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ (2006) Kidney Int 69(6): 1064-72
    › Primary publication · 16528256 (PubMed)
  2. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. Yang HC, Ma LJ, Ma J, Fogo AB (2006) Kidney Int 69(10): 1756-64
    › Primary publication · 16598202 (PubMed)
  3. Membranous glomerulopathy with spherules: an uncommon variant with obscure pathogenesis. Kowalewska J, Smith KD, Hudkins KL, Chang A, Fogo AB, Houghton D, Leslie D, Aitchison J, Nicosia RF, Alpers CE (2006) Am J Kidney Dis 47(6): 983-92
    › Primary publication · 16731293 (PubMed)
  4. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I (2006) J Am Soc Nephrol 17(10): 2832-43
    › Primary publication · 16988066 (PubMed)
  5. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC (2006) J Am Soc Nephrol 17(10): 2664-9
    › Primary publication · 16971655 (PubMed) · PMC4618687 (PubMed Central)
  6. Diabetic nephropathy. Giannico G, Miller FJ, Fogo AB (2006) Am J Kidney Dis 47(5): A42, e61-3
    › Primary publication · 16637105 (PubMed)
  7. Can glomerulosclerosis be reversed? Fogo AB (2006) Nat Clin Pract Nephrol 2(6): 290-1
    › Primary publication · 16932443 (PubMed)
  8. Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction. Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V (2006) J Am Soc Nephrol 17(2): 433-41
    › Primary publication · 16371432 (PubMed)
  9. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB (2006) J Am Soc Nephrol 17(7): 1886-95
    › Primary publication · 16790514 (PubMed)
  10. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB (2005) J Am Soc Nephrol 16(4): 966-76
    › Primary publication · 15728787 (PubMed)